Showing results (1211-1220 of 1,275) with videos related to
Sort By:
Pageof 128
Veterinary and Comparative Oncology|August 18, 2018
Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumoursCharlène Rico, Derek Boerboom, Marilène PaquetVeterinary and Comparative Oncology|August 22, 2018
Expression and prognostic value of c-met in canine mammary tumoursYi-Chen Chen, Ying-Yu Chen, Jiunn-Wang Liao, et al.Veterinary and Comparative Oncology|September 6, 2018
Evaluation of intravenous and subcutaneous administration of a novel, excipient-free, nanoparticulate formulation of paclitaxel in dogs with spontaneously occurring neoplasiaKim A Selting, Sandra M Bechtel, Jahna Espinosa, et al.Veterinary and Comparative Oncology|August 14, 2018
Targeting NEDD8-activating enzyme is a new approach to treat canine diffuse large B-cell lymphomaA L F V Assumpção, Z Lu, K W Marlowe, et al.Veterinary and Comparative Oncology|August 30, 2018
Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcomaSita S Withers, Katherine A Skorupski, Daniel York, et al.Veterinary and Comparative Oncology|May 17, 2017
LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphomaP M Brown, S Tzannes, S Nguyen, et al.Veterinary and Comparative Oncology|June 13, 2018
The impact of extirpation of non-palpable/normal-sized regional lymph nodes on staging of canine cutaneous mast cell tumours: A multicentric retrospective studyR Ferrari, L Marconato, P Buracco, et al.Veterinary and Comparative Oncology|February 18, 2015
Tumourigenic canine osteosarcoma cell lines associated with frizzled-6 up-regulation and enhanced side population cell frequencyL C de Sá Rodrigues, K E Holmes, V Thompson, et al.Veterinary and Comparative Oncology|June 12, 2014
Antagonism of serotonin receptor 1B decreases viability and promotes apoptosis in the COS canine osteosarcoma cell lineA K Viall, C P Goodall, B Stang, et al.Veterinary and Comparative Oncology|January 23, 2014
Polymorphism of P53-Ets/AP1 transactivation region of MDM2 oncogene and its immunohistochemical analysis in canine tumoursA Rezaie, M R Tabandeh, S M A NooriPageof 128